RecruitingNCT05826457

North American Prodromal Synucleinopathy Consortium Stage 2

Studying Multiple system atrophy

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Washington University School of Medicine
Principal Investigator: Yo-El Ju, MD, MCSI
Washington University School of Medicine
Enrollment: 500 target
Eligibility: 18 years · All sexes
Timeline: 2022 – 2025

Study locations (9)

University of California Los Angeles, Los Angeles, California, United States
Stanford University, Redwood City, California, United States
Emory University, Atlanta, Georgia, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
University of Minnesota, Minneapolis, Minnesota, United States
Mayo Clinic Rochester, Rochester, Minnesota, United States
Washington University School of Medicine, St Louis, Missouri, United States
Oregon Health Sciences University, Portland, Oregon, United States
McGill University Health Centre Research Institute, Montreal, Quebec, Canada

Collaborators

Mayo Clinic · University of Minnesota · University of California, Los Angeles · McGill University · Emory University · Massachusetts General Hospital · National Institute of Neurological Disorders and Stroke (NINDS) · Stanford University · National Institutes of Health (NIH) · Oregon Health and Science University · National Institute on Aging (NIA)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05826457 on ClinicalTrials.gov

Other trials for Multiple system atrophy

Additional recruiting or active studies for the same condition.

See all trials for Multiple system atrophy →

← Back to all trials